Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lynn Henry

Showing results (181-190 of 195) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineCarolyn D Runowicz, Corinne R Leach, N Lynn Henry, et al.
CA: a Cancer Journal for Clinicians|December 8, 2015
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineCarolyn D Runowicz, Corinne R Leach, N Lynn Henry, et al.
JCO Precision Oncology|July 29, 2024
TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast CancerChristos Vaklavas, Cindy B Matsen, Zhengtao Chu, et al.
Journal of the National Cancer Institute|October 1, 2011
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working groupMitch Dowsett, Torsten O Nielsen, Roger A'Hern, et al.
Breast Cancer Research and Treatment|November 2, 2011
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancerAditya Bardia, Erin T Arieas, Zhe Zhang, et al.
JAMA Network Open|April 10, 2026
Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage CancerMeghna S Trivedi, Joseph M Unger, N Lynn Henry, et al.
Journal of the National Cancer Institute|October 21, 2022
Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trialsMichael E Roth, Susan K Parsons, Patricia A Ganz, et al.
Pharmacogenomics|August 24, 2023
Effects of <i>CYP3A4</i> and <i>CYP2C9</i> genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226Delaney V Rutherford, Sarah Medley, Nicholas C Henderson, et al.
Journal of Patient-Reported Outcomes|July 10, 2020
A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013Siu-Fun Wong, Joseph M Unger, James L Wade, et al.
JAMA Oncology|December 11, 2025
Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical TrialIrene M Kang, Jamie K Forschmiedt, Michelle M Loch, et al.
Pageof 20

Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineCarolyn D Runowicz, Corinne R Leach, N Lynn Henry, et al.
CA: a Cancer Journal for Clinicians|December 8, 2015
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineCarolyn D Runowicz, Corinne R Leach, N Lynn Henry, et al.
JCO Precision Oncology|July 29, 2024
TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast CancerChristos Vaklavas, Cindy B Matsen, Zhengtao Chu, et al.
Journal of the National Cancer Institute|October 1, 2011
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working groupMitch Dowsett, Torsten O Nielsen, Roger A'Hern, et al.
Breast Cancer Research and Treatment|November 2, 2011
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancerAditya Bardia, Erin T Arieas, Zhe Zhang, et al.
JAMA Network Open|April 10, 2026
Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage CancerMeghna S Trivedi, Joseph M Unger, N Lynn Henry, et al.
Journal of the National Cancer Institute|October 21, 2022
Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trialsMichael E Roth, Susan K Parsons, Patricia A Ganz, et al.
Pharmacogenomics|August 24, 2023
Effects of <i>CYP3A4</i> and <i>CYP2C9</i> genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226Delaney V Rutherford, Sarah Medley, Nicholas C Henderson, et al.
Journal of Patient-Reported Outcomes|July 10, 2020
A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013Siu-Fun Wong, Joseph M Unger, James L Wade, et al.
JAMA Oncology|December 11, 2025
Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical TrialIrene M Kang, Jamie K Forschmiedt, Michelle M Loch, et al.
Pageof 20